Glioblastoma is the most common type of primary, malignant brain tumour. It's very aggressive, with an average survival of less than a year and fewer than 10% of patients surviving five years.
Story
Thanks for taking the time to visit my JustGiving page.
This is a fund raiser for a clinicalimmunotherapy trial for Glioblastoma. I looked at taking this but decided not to in 2017 but due to lack of data and cost.
My oncologist, Dr Paul Mulholland is leading this. This will help me and other patients.
Share this story
Help Patrick Melville
Sharing this page with your friends could help raise up to 3x more in donations
Glioblastoma is the most common type of primary, malignant brain tumour. It's very aggressive, with an average survival of less than a year and fewer than 10% of patients surviving five years.
There are 14.7million people – that’s more than one in six – in the UK living with a neurological condition. Here at the country's leading neurological centre, we’re passionate about supporting the hospital to help improve the lives of patients through treatment and research.